Tuberculosis Research
- 13 November 1996
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 276 (18) , 1512-1513
- https://doi.org/10.1001/jama.1996.03540180068036
Abstract
Tuberculosis (TB) is a killer with impressive credentials. Over the past 2 centuries, it has killed a billion people.1Currently it is the leading cause of mortality from a single infectious agent—accounting for 26% of preventable adult deaths in the developing world.2In the coming decade, it is slated to kill at least 30 million people.3 See also p 1502. The synergy between the epidemics of TB and human immunodeficiency virus (HIV) constitutes a global public health crisis of staggering dimensions. In persons infected with HIV, infection withMycobacterium tuberculosisis much more likely to progress rapidly to active disease, which is increasingly difficult to diagnose and more complicated to treat.4Globally, TB is now the leading cause of death among persons with acquired immunodeficiency syndrome (AIDS), killing 1 of every 3 people who die with AIDS.3To date, the dual scourge of TB andKeywords
This publication has 9 references indexed in Scilit:
- Drug Resistance in Mycobacterium tuberculosisPublished by IntechOpen ,2018
- Bacille Calmette–Guerin and Prospects for New Vaccines against TuberculosisPublished by Taylor & Francis ,2014
- Control Strategies for Tuberculosis Epidemics: New Models for Old ProblemsScience, 1996
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995
- Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosisScience, 1995
- Genetic control of host resistance to infectionTrends in Genetics, 1994
- The promise of immunotherapy for tuberculosisRespiratory Medicine, 1994
- Tuberculosis in patients with HIV infectionMedical Clinics of North America, 1993
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992